Elevance Health (ELV) Common Equity (2009 - 2026)

Elevance Health (ELV) has 18 years of Common Equity data on file, last reported at $44.0 billion in Q1 2026.

• Common Equity for Q1 2026 came in at $44.0 billion, up 3.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.0 billion (up 3.34% YoY), and the FY2025 annual result was $43.9 billion, up 5.93% from the prior year.
• Common Equity held at $44.0 billion in Q1 2026 per ELV's latest filing, from $43.9 billion in the prior quarter.
• Over five years, Common Equity peaked at $44.1 billion in Q3 2025 and troughed at $35.9 billion in Q2 2022.
• A 5-year average of $40.3 billion and a median of $40.7 billion in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2025: Common Equity rose 13.86% in 2024, then increased 0.46% in 2025.
• A 5-year view of Common Equity shows it stood at $36.3 billion in 2022, then climbed by 8.46% to $39.4 billion in 2023, then advanced by 5.13% to $41.4 billion in 2024, then increased by 5.93% to $43.9 billion in 2025, then climbed by 0.36% to $44.0 billion in 2026.
• Business Quant data shows ELV's Common Equity at $44.0 billion in Q1 2026, $43.9 billion in Q4 2025, and $44.1 billion in Q3 2025.